Page last updated: 2024-08-23

staurosporine and cx 4945

staurosporine has been researched along with cx 4945 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M1
Chang, JW; Jo, J; Kim, J; Lee, S; Sim, J; Yun, H1

Reviews

2 review(s) available for staurosporine and cx 4945

ArticleYear
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
    Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22

    Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases

2018
Recent advances in development of hetero-bivalent kinase inhibitors.
    European journal of medicinal chemistry, 2021, Apr-15, Volume: 216

    Topics: Cyclic AMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Receptor, EphA1; Small Molecule Libraries; src-Family Kinases; TOR Serine-Threonine Kinases

2021